SELENOMETHIONINE SE 75 Drug Patent Profile
✉ Email this page to a colleague
When do Selenomethionine Se 75 patents expire, and when can generic versions of Selenomethionine Se 75 launch?
Selenomethionine Se 75 is a drug marketed by Ge Healthcare, Mallinckrodt, and Pharmalucence. and is included in three NDAs.
The generic ingredient in SELENOMETHIONINE SE 75 is selenomethionine se-75. There is one drug master file entry for this compound. Additional details are available on the selenomethionine se-75 profile page.
Summary for SELENOMETHIONINE SE 75
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 12 |
| Clinical Trials: | 10 |
| Patent Applications: | 98 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | SELENOMETHIONINE SE 75 at DailyMed |
Recent Clinical Trials for SELENOMETHIONINE SE 75
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cancer Trials New Zealand | Phase 1 |
| Waikato Hospital | Phase 1 |
| Counties Manukau Health | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for SELENOMETHIONINE SE 75
US Patents and Regulatory Information for SELENOMETHIONINE SE 75
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | SELENOMETHIONINE SE 75 | selenomethionine se-75 | INJECTABLE;INJECTION | 017257-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mallinckrodt | SELENOMETHIONINE SE 75 | selenomethionine se-75 | INJECTABLE;INJECTION | 017098-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Pharmalucence | SELENOMETHIONINE SE 75 | selenomethionine se-75 | INJECTABLE;INJECTION | 017322-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
